The US Food and Drug Administration has approved Eyenovia eye drops to reduce inflammation and pain in patients who have undergone eye surgery, Taiwan-based Formosa Pharmaceuticals said. Eyenovia acquired commercial rights to the drug in the US last August from Formosa.